Ensysce Biosciences ENSC
NASDAQ ENSC
$0.47 -0.04 (-7.93%)
At close: Oct 23, 2026 · 4:00 PM EDT

Ensysce Biosciences (ENSC) Amortization of Deferred Charges (2020 - 2025)

Updated

Analysis

Ensysce Biosciences (ENSC) Amortization of Deferred Charges (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Ensysce Biosciences 1.20 Mn -10.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 300,000.00
Jun 30, 2024 25,735.00
Mar 31, 2024 1.17 Mn
Jun 30, 2020 188,572.00
Mar 31, 2020 31,428.00
API Access

Ensysce Biosciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=ENSC&period=max&api_key=YOUR_API_KEY